Clinical Trial Update: Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma

View source ↗

Summary

A clinical trial update examining the expression of AMP-activated Protein Kinase (AMPK) protein in lung adenocarcinoma; current trial status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Snippet

Sponsor: China Medical University Hospital | Conditions: Lung Adenocarcinoma | Status: UNKNOWN